Dr. Jeffrey R. Jay, M.D.

Great Point Partners as of Dec. 31, 2016

Portfolio Holdings for Great Point Partners

Great Point Partners holds 34 positions in its portfolio as reported in the December 2016 quarterly 13F filing

Company (Ticker) Portfolio Weight Valued At Change in Shares Share Count Share Price
Adamas Pharmaceuticals 9.0 $44M 2.6M 16.90
Foamix Pharmaceuticals 6.8 $33M 3.0M 11.10
Vanda Pharmaceuticals (VNDA) 6.6 $32M 2.0M 15.95
Synergy Pharmaceuticals 6.2 $30M 5.0M 6.09
Zogenix 6.1 $30M 2.4M 12.15
Neurocrine Biosciences (NBIX) 6.0 $29M 750k 38.70
Enanta Pharmaceuticals (ENTA) 5.7 $28M 828k 33.50
Medicines Company 5.2 $26M 750k 33.94
Ignyta 4.4 $21M 4.0M 5.30
Merrimack Pharmaceuticals In 4.2 $20M 5.0M 4.08
Sage Therapeutics (SAGE) 4.0 $20M 386k 51.06
Avexis 4.0 $20M 413k 47.73
Therapeuticsmd 3.9 $19M 3.3M 5.77
Trevena 3.6 $18M 3.0M 5.88
Colucid Pharmaceuticals 3.3 $16M 438k 36.40
Global Blood Therapeutics In 3.0 $15M 1.0M 14.45
Dbv Technologies S A (DBVT) 2.7 $13M 370k 35.13
Bovie Medical Corporation 2.2 $11M 3.1M 3.59
Inotek Pharmaceuticals 1.9 $9.2M 1.5M 6.10
ACADIA Pharmaceuticals (ACAD) 1.6 $7.8M 270k 28.84
BioCryst Pharmaceuticals (BCRX) 1.6 $7.8M 1.2M 6.33
Connecture 1.4 $6.9M 4.1M 1.68
Sunesis Pharmaceuticals Inc Ne 1.1 $5.6M 1.5M 3.62
Myovant Sciences 0.9 $4.4M 350k 12.44
Mirati Therapeutics 0.8 $4.1M 870k 4.75
Ocera Therapeutics 0.8 $4.1M 2.0M 2.10
Dermira 0.7 $3.5M 114k 30.33
Alimera Sciences 0.5 $2.5M 2.3M 1.08
Tenax Therapeutics 0.4 $2.2M 1.1M 1.95
Catabasis Pharmaceuticals 0.4 $2.0M 557k 3.61
Alnylam Pharmaceuticals (ALNY) 0.4 $1.9M 52k 37.43
Aradigm 0.3 $1.3M 792k 1.60
Streamline Health Solutions (STRM) 0.0 $190k 152k 1.25
Ophthotech 0.0 $34k 7.1k 4.79